Answers are grounded in this paper and cite their sources.
Skeletal muscle dysfunction is increasingly recognized in Alzheimer's disease (AD), but its pathological basis remains poorly understood. We examined age-associated muscle dysfunction together with skeletal muscle and spinal motor system alterations in male App NL-G-F/NL-G-F knock-in ( App -KI) mice, which develop age-dependent amyloid-β (Aβ) pathology without amyloid precursor protein (APP) overexpression. Middle-aged, but not adult, App -KI mice showed lower strength-related performance than age-matched wild-type mice, whereas skeletal muscle mass and myofiber cross-sectional area were preserved. General motor performance was also preserved, suggesting that the strength-related impairment did not simply reflect generalized motor dysfunction. Middle-aged App -KI mice had higher percentages of centrally nucleated fibers in the gastrocnemius and quadriceps femoris muscles. Transcriptomic and targeted expression analyses further revealed alterations in molecular profiles related to muscle development and myosin, including reduced expression of factors involved in myoblast fusion and selected myosin proteins. Despite evident cerebral Aβ pathology, no apparent Aβ immunoreactivity was detected in skeletal muscle. In the lumbar ventral horn, App -KI mice had fewer choline acetyltransferase-positive motor neurons, greater Aβ deposition, and increased immunoreactivity for glial fibrillary acidic protein and ionized calcium-binding adapter molecule 1; serum interleukin-6 levels were also selectively elevated in middle-aged App -KI mice. Together, these findings indicate that age-associated reductions in strength-related performance in App -KI mice occur without overt muscle atrophy and are accompanied by histological and molecular abnormalities in skeletal muscle and pathological changes in the lumbar spinal cord. Thus, AD-related physical dysfunction may involve abnormalities in both peripheral skeletal muscle and the spinal motor system.
No takes yet. Share an insight, caveat, or question.
NAKAI et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: